Technical Analysis for RP - Replicel Life Sciences Inc.

Grade Last Price % Change Price Change
F 0.010 0.00% 0.000
RP closed down 33.33 percent on Thursday, November 14, 2024, on 53 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Nov 26
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Down Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction -33.33%
Wide Bands Range Expansion -33.33%
Oversold Stochastic Weakness -33.33%
Narrow Range Bar Range Contraction -33.33%
Wide Bands Range Expansion -33.33%
Gapped Down Weakness -33.33%

   Recent Intraday Alerts

Alert Time
Down 5% 6 days ago
Down 3% 6 days ago
Down 2% 6 days ago
Down 1% 6 days ago
Fell Below 10 DMA 6 days ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Replicel Life Sciences Inc. Description

RepliCel Life Sciences Inc. is a regenerative medicine company focused on developing autologous cell therapies that treat functional cellular deficits. The Company's product pipeline includes RCT-01-Tendon Repair, RCS-01-Skin Rejuvenation, RCH-01-Hair Regeneration and RCI-02-Dermal Injector. RCT-01 is an autologous cell-based treatment utilizing non-bulbar dermal sheath cells isolated from the hair follicle sheath to treat chronic tendinosis caused by acute and chronic tensile overuse. RCH-01 also utilizes dermal sheath cup cells isolated from the hair follicle to treat androgenetic alopecia. RCI-02 is a dermal injector designed to control intradermal (dermis), subcutaneous (fat) or intramuscular injections. It is designed to support the injection of RCH-01 and RCS-01 cell therapy products. The injector has applications for dermatological procedures requiring injections of specific volumes of material at specific depths, including cellular products, fillers and collagen injections.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pipe Pipeline Science RTT Skin Volume Life Sciences Therapy Organ Systems Regenerative Medicine Collagen Anatomy Cell Therapy

Is RP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.25
52 Week Low 0.01
Average Volume 41,733
200-Day Moving Average 0.117
50-Day Moving Average 0.052
20-Day Moving Average 0.031
10-Day Moving Average 0.015
Average True Range 0.008
RSI (14) 36.71
ADX 22.11
+DI 24.617
-DI 40.397
Chandelier Exit (Long, 3 ATRs) 0.046
Chandelier Exit (Short, 3 ATRs) 0.034
Upper Bollinger Bands 0.072
Lower Bollinger Band -0.010
Percent B (%b) 0.25
BandWidth 265.806
MACD Line -0.014
MACD Signal Line -0.014
MACD Histogram -0.0001
Fundamentals Value
Market Cap 335.23 Thousand
Num Shares 33.5 Million
EPS -0.14
Price-to-Earnings (P/E) Ratio -0.07
Price-to-Sales 26.34
Price-to-Book 0.00
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.010
Resistance 3 (R3) 0.010 0.010 0.010
Resistance 2 (R2) 0.010 0.010 0.010 0.010
Resistance 1 (R1) 0.010 0.010 0.010 0.010 0.010
Pivot Point 0.010 0.010 0.010 0.010 0.010
Support 1 (S1) 0.010 0.010 0.010 0.010 0.010
Support 2 (S2) 0.010 0.010 0.010 0.010
Support 3 (S3) 0.010 0.010 0.010
Support 4 (S4) 0.010